Latest Beta secretase Stories
Like two unruly boys who need to be split up in class, a pair of protein molecules work together to speed up the toxic events of Alzheimer's disease.
A dysfunction in the lining of blood vessels that is linked to cardiovascular illness also appears to play a role in the development of Alzheimerâ€™s disease.
A protein known to exist in the brain for more than 30 years, called 5-lipoxygenase, has been found to play a regulatory role in the formation of the amyloid beta in the brain, the major component of plaques implicated in the development of Alzheimer's disease.
A team of neuroscientists has discovered important new information in the search for an effective treatment for Alzheimer's disease, the debilitating neurological disorder that afflicts more than 5.3 million Americans and is the sixth-leading cause of death in the United States.
Mount Sinai School of Medicine researchers have found that a gene associated with the onset of Type 2 diabetes also is found at lower-than-normal levels in people with Alzheimer's disease.
The first trial of a new model for testing Alzheimer's treatments has reassured researchers that a promising class of drugs does not exacerbate the disease if treatment is interrupted.
Researchers have discovered how mutations in the presenilin 1 gene cause early-onset Alzheimer's disease (AD).
Researchers at Tufts University School of Medicine have zeroed in on a protein that may play a role in the progression of Alzheimer's disease.
U.S. researchers say they are testing gammaglobulin as a treatment to help slow the progress of Alzheimer's disease. The study -- called the Gammaglobulin Alzheimer's Partnership Study -- is recruiting 360 participants at 36 sites nationwide.
- A transitional zone between two communities containing the characteristic species of each.